Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Senmiao Biotech is a Chinese biotechnology company specializing in the cultivation, research, and commercialization of Dendrobium candidum, a highly valued medicinal herb in Traditional Chinese Medicine (TCM). The company operates a large-scale, standardized cultivation base and utilizes advanced extraction technologies to produce high-quality health supplements and pharmaceutical intermediates. Its product portfolio includes Dendrobium capsules, powders, and functional beverages aimed at improving immune function and managing chronic conditions. Senmiao Biotech is recognized as a National High-tech Enterprise and focuses on integrating modern biotechnology with traditional herbal science to serve the growing wellness market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Senmiao.